The evolution of skin notations for occupational risk assessment: A new NIOSH strategy

Regulatory Toxicology and Pharmacology

Volumn 61, Issue 1, 2011, Pages 53-62

  Dotson, G Scott ^a   Chen, Chen Peng ^b   Gadagbui, Bernard ^c   Maier, Andrew ^c   Ahlers, Heinz W ^a   Lentz, Thomas J ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c Toxicology Excellence for Risk Assessment   (United States)

Author keywords

Chemicals; Hazard characterization; Occupational; Risk assessment; Skin; Skin notations

Indexed keywords

ACRYLAMIDE;

ARTICLE; CHEMICAL ACCIDENT; CHEMICAL CARCINOGENESIS; HAZARD ASSESSMENT; HEALTH HAZARD; HUMAN; INFORMATION SYSTEM; LD 50; MATHEMATICAL MODEL; NONHUMAN; OCCUPATIONAL HAZARD; OCCUPATIONAL TOXICOLOGY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RISK ASSESSMENT; SKIN ABSORPTION; SKIN ALLERGY; SKIN NOTATION; SKIN PERMEABILITY; SKIN PROTECTION; SKIN TOXICITY; SYSTEMIC DISEASE; TOXICOKINETICS;

ANIMALS; FEMALE; HAZARDOUS SUBSTANCES; HUMANS; MALE; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH (U.S.); OCCUPATIONAL EXPOSURE; RISK; RISK ASSESSMENT; SKIN; SKIN DISEASES; UNITED STATES;

EID: 80052421857     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2011.06.002     Document Type: Article

References (59)

1. ACGIH, 2009. Introduction to the Chemical Substances-Definitions and notations. In: Documentation of the TLVs and BEIs with other worldwide occupational exposure values, CD-ROM version. American Conference of Governmental Industrial Hygienists, Cincinnati, OH.
2. Adler I.D., Gonda H., Hrabe de Angelis M., Jentsch I., Otten I.S., Speicher M.R. Heritable translocations induced by dermal exposure of male mice to acrylamide. Cytogenet. Genome Res. 2004, 104(1-4):271-276.
3. Allan, S., 1995. CT-566-94 Acrylamide skin sensitisation in the guinea pig. Huntingdon Research Centre Ltd., Huntingdon, Cambridgeshire, England. Report No. CTI 2/940899/55.
4. American Cyanamid Company, 1952. Preliminary patch tests with acrylamide in 25 persons. American Cyanamid Company, Toxicology and Product Safety Department, Pittsburgh, PA. TSCA Section 8(d) Health and Safety Study Admission. USEPA, OPPT, TSCATS. NTIS Report No. OTS-0206055. Doc#: 878211663. Available upon request via http://www.oppt.ncic@epa.gov.
5. American Cyanamid Company, 1973. Range finding studies: single oral, single dermal (FHSA), single inhalation. TSCA Section 8(d) Health and Safety Study Admission. USEPA, OPPT, TSCATS. Doc#: 878211677. Available upon request via http://www.oppt.ncic@epa.gov.
6. Bachmann M., Myers J.E., Bezuuidenhout B.N. Acrylamide monomer and peripheral neuropathy in chemical workers. Am. J. Ind. Med. 1992, 21:217-222.
7. Beck L.A., Leung D.Y.M. Allergen sensitization through the skin induces systemic allergic responses. J. Allergy Clin. Immunol. 2000, 106:S258-S263.
8. Bello D., Herrick C.A., Smith T.J., Woskie S.R., Streicher R.P., Cullen M.R., Liu Y., Redlich C.A. Skin exposures to isocyanates: reasons for concerns. Environ. Health Perspect. 2007, 115:328-335.
9. Boogrard P.J. Biomonitoring as a tool in the human health risk characterization of skin exposure. Hum. Exp. Toxicol. 2008, 27:297-305.
10. Bos P.M., Brouwer D.H., Stevenson H., Boogaard P.J., de Kort W.L., van Hemmen J.J. Proposal for the assessment of quantitative skin exposure limits in occupational environments. Part I. Development of a concept for the derivation of a quantitative skin occupational exposure limit. Occup. Environ. Med. 1998, 55:795-804.
11. Bouwman T., Cronin M.T., Bessems J.G.M., van de Sandt J.J. Improving the applicability of (Q)SARs for percutaneous penetration in regulatory risk assessment. Hum. Exp. Toxicol. 2008, 27:269-276.
12. Brouwer D.H., Hoogendoorn L., Bos P.M., Boogaard P.J., van Hemmen J.J. Proposal for the assessment of quantitative skin exposure limits in occupational environments. Part II. Feasibility study for application in an exposure scenario for MDA. Occup. Environ. Med. 1998, 55:805-811.
13. Bull R.J., Robinson M., Laurie R.D., Stoner G.D., Greisiger E., Meier J.R., Stober J. Carcinogenic effects of acrylamide in Sencar and A/J mice. Cancer Res. 1984, 44(1):107-111.
14. Chen C.P., Boeinger M.F., Ahlers H.W. Use of skin LD50 as a criterion for skin notation. Appl. Occup. Environ. Hyg. 2003, 18:154-155.
15. Chen C.P., Ahlers H.W., Dotson G.S., Lin Y.C., Chang W.C., Maier A., Gadagbui B. Efficacy of predictive modeling as a scientific criterion in dermal hazard identification for assignment of skin notations. Reg Toxicol Pharmacol 2011.
16. Czerczak S., Kupczewska M. Assignment of skin notation for Maximum Allowable Concentration (MAC) list in Poland. Appl. Occup. Environ. Hyg. 2002, 17:187-199.
17. Day G.A., Stefaniak A.B., Weston A., Tinkle S. Beryllium exposure: dermal and immunological considerations. Int. Arch. Occup. Environ. Health. 2006, 79:161-164.
18. Dow Chemical USA, 1975. Acute toxicological properties and industrial handling hazards of a 50% aqueous solution of acrylamide. Dow Chemical Company, Midland, MI. On file with the U.S. Environmental Protection Agency under TSCA Section 8D. OTS #0206684. Document #878214838.
19. Drees D.T., Crago F.L., Hopper C.R., Smith J.M. Subchronic percutaneous toxicity of acrylamide and methacrylamide in the newborn rabbit. Toxicol. Appl. Pharmacol. 1976, 37:190.
20. Drexler H., Goen T., Schaller K.H. Biological tolerance values: change in a paradigm concept from assessment of a single value to use of an average. Int. Arch. Occup. Environ. Health. 2002, 82:139-142.
21. Eastman Kodak Company, 1978. Toxicity and health hazard summary. TSCA Section 8(d) Health and Safety Study Admission. USEPA, OPPT, TSCATS. NTIS Report No. OTS #0206536. Document #878214376. Available upon request via http://www.oppt.ncic@epa.gov.
22. ECB, 2002. European Chemicals Bureau, Institute for Health and Consumer Protection, European Commission Joint Research Centre. European Union risk assessment report: acrylamide. Vol. 24. Office for Official Publications of the European Communities, Luxembourg. http://www.ecb.jrc.it/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/acrylamidereport011.pdf.
23. ECB, 2011. European Chemicals Bureau, Institute for Health and Consumer Protection, European Commission Joint Research Centre. European INventory of Existing Commercial chemical Substances (EINECS): Acrylamide. http://www.ecb.jrc.ec.europa.eu/esis/.
24. ECETOC, 1998. European Centre for Ecotoxicology and Toxicology of Chemicals. Special Report No. 15: Examination of a proposed skin notation strategy. Brussels, Belgium.
25. European Parliament, Council of the European Union, 2008. Regulation (EC) No. 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labeling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No. 1907/2006. OJEU, Off. J. Eur. Union L353:1-1355 http://www.eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:353:0001:1355:EN:PDF.
26. Fennell T.R., Sumner S.C.J., Snyder R.W., Burgess J., Friedman M.A. Kinetics of elimination of urinary metabolites of acrylamide in humans. Toxicol. Sci. 2006, 93:256-267.
27. Fenske R.A. State-of-the-art measurement of agricultural pesticide exposures. Scand. J. Work Environ. Health 2005, 31(Suppl. 1):67-73.
28. Fiserova-Bergerova V., Pierce J.T., Droz P.O. Skin absorption potential of industrial chemicals: criteria for skin notation. Am. J. Ind. Med. 1990, 17:617-635.
29. Gutierrez-Espeleta G.A., Hughes L.A., Piegorsch W., Shelby M.D., Generoso W.M. Acrylamide: dermal exposure produces genetic damage in male mouse germ cells. Fund Appl. Toxicol. 1992, 18:189-192.
30. He F., Zhang S., Wang H., Li G., Zhang Z.M., Li F.L., Dong X.M., Hu F.R. Neurological and electroneuromyographic assessment of the adverse effects of acrylamide on occupationally exposed workers. Scand J. Work Environ. Health 1989, 15:125-129.
31. ICCVAM, 2009. Interagency Coordinating Committee on the Validation of Alternative Methods. Recommended performance standards: murine local lymph node assay. National Toxicology Program, Interagency Center for the Evaluation of Alternative Toxicology Methods. NIH Publication No. 09-7357. http://www.iccvam.niehs.nih.gov/docs/immunotox_docs/llna-ps/LLNAPerfStds.pdf.
32. Johanson, G., Rauma, M., 2008. Basis for skin notation. Part 1. Skin penetration data for substances on the Swedish OEL list. Aarbete Och Hälsa (Work and Health) series. Occupational and Environmental Medicine, Sahlgrenska Academy, Göteborg University, Sweden. http://www.gupea.ub.gu.se/dspace/bitstream/2077/9876/1/ah2008_2.pdf.
33. Kimber I. The role of the skin in the development of chemical respiratory hypersensitivity. Toxicol. Lett. 1996, 889:92.
34. Kissel J.C. The mismeasure of dermal absorption. J. Expo. Sci. Environ. Epidemiol. 2010, 28:1-8.
35. Kupczewska-Dobewcka M., Czercak S. The skin notation in the MAC list and classification of dangerous chemicals. Int. J. Occup. Med. Environ. Health 2006, 19:84-91.
36. Lavoue J., Milon A., Droz P.O. Comparison of the indices proposed as criteria for assigning skin notations. Ann. Occup. Hyg. 2008, 52:747-756.
37. McCollister D., Oyen F., Rowe V. Toxicology of acrylamide. Toxicol. Appl. Pharmacol. 1964, 6:172-181.
38. Mukhtar H., Dixit R., Seth P. Reduction in cutaneous and hepatic glutathione contents, glutathione-S-transferases and aryl hydrocarbon hydroxylase activities following topical application of acrylamide to mouse. Toxicol. Lett. 1981, 9:153-156.
39. Nielsen J.B., Grandjean P. Criteria for skin notation in different countries. Am. J. Ind. Med. 2004, 45:275-280.
40. NIOSH, 1991. NIOH and NIOSH basis for an occupational health standard. Acrylamide: a review of the literature. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati, Ohio. DHHS (NIOSH) Publication No. 91-115. http://www.cdc.gov/niosh/91-115.html.
41. NIOSH, 2005. NIOSH pocket guide to chemical hazards. DHHS, CDC, NIOSH, Cincinnati, Ohio. DHHS (NIOSH) Publication No. 2005-149. http://www.cdc.gov/niosh/npg/default.html.
42. NIOSH, 2009. Current intelligence bulletin 61: a strategy for assigning new NIOSH skin notations. DHHS, CDC, NIOSH, Cincinnati, Ohio. DHHS (NIOSH) Publication No. 2009-147. http://www.cdc.gov/niosh/docs/2009-147/.
43. NIOSH, 2011. Skin notation profile: Acrylamide. DHHS, CDC, NIOSH, Cincinnati, Ohio. DHHS (NIOSH) Publication No. 2011-139. http://www.cdc.gov/niosh/docs/2011-139/pdfs/2011-139.pdf.
44. Novikova E.E. Toxic effect of acrylamide after entering through the skin. Gig Sanit 1979, 10:73-74.
45. OECD (Council of the European Communities), 1992. Council Directive 92/32/EEC of 30 April 1992 amending for the seventh time Directive 67/548/EEC on the approximation of the laws, regulations, and administrative provisions relating to the classification, packaging, and labeling of dangerous substances. Off. J. Euro. Commun. L 154 (5.6.92).
46. OSHA, 2007. Occupational Safety and Health Administration hazard information bulletin: acrylamide exposure during chemical grouting operations. US Department of Labor, OSHA, Washington, DC. http://www.osha.gov/dts/hib/hib_data/hib19900727.html.
47. Pauluhn J. Brown Norway rat asthma model of diphenylmethane-4,4'-diisocyanate (MDI): analysis of the elicitation dose-response relationship. Toxicol. Sci. 2008, 104(2):320-331.
48. Redlich C.A., Herrick C.A. Lung/skin connections in occupational lung disease. Curr. Opin. Allergy Clin. Immunol. 2008, 8:115-119.
49. Sartorelli P. Skin exposure assessment in occupational medicine. Occup. Med. (Oxf) 2002, 53:151-156.
50. Sartorelli P., Ahlers H.W., Alanko K., Chen-Peng C., Cherrie J.W., Drexler H., Kezic S., Johanson G., Larese Filon F., Maina G., Montomoli L., Nielsen J.B. How to improve skin notations: position paper from a workshop. Regul. Toxicol. Pharmacol. 2007, 49:301-307.
51. Sartorelli P., Ahlers H.W., Cherrie J.W., Kezic S., Johanson G., Filon F.L., Nielsen J.B., Shepherd A., Stull J., Williams F. The 2008 ICOH Workshop on skin notations. Med. Lav. 2010, 101:3-8.
52. Sithamparanadarajah R. Diseases Caused by Dermal Exposures to Chemicals. Controlling Skin Exposure to Chemicals and Wet-Work: A Practical Book 2008, 15-24. RMS Publishing, Stourbridge, U.K., (Chapter 3). P.G. Evans (Ed.).
53. SRC, 2009. Syracuse Research Corporation, Interactive PhysProp database demo. http://www.srcinc.com/what-we-do/databaseforms.aspx?id=386.
54. Sumner S., Williams C., Snyder R., Krol W., Asgharian B., Fennell T. Acrylamide: a comparison of metabolism and hemoglobin adducts in rodents following dermal, intraperitoneal, oral, or inhalation exposure. Toxicol. Sci. 2003, 75:260-270.
55. UNECE, 2007. Globally harmonized system of classification and labeling of chemicals (GHS). 2nd revised edition. United Nations Economic Commission for Europe, Geneva, Switzerland. http://www.unece.org/trans/danger/publi/ghs/ghs_rev02/02files_e.html.
56. USEPA, 2003. Framework for Cumulative Risk Assessment. Document# EPA/630/P-02/001F. Risk Assessment Forum, United States Environmental Protection Agency, Washington, D.C.
57. van de Sandt J.J., Dellarco M., Van Hemmen J.J. From dermal exposure to internal dose. J. Expo. Sci. Environ. Epidemiol. 2007, 17(Suppl. 1):S38-47.
58. Van Nimmen N.F., Poels K.L., Severi M.J., Godderis L., Veulemans H.A. Selecting an appropriate biomonitoring strategy to evaluate dermal exposure to opioid narcotic analgesics in pharmaceutical production workers. Occup. Environ. Med. 2010, 67:464-470.
59. WHO, 2006. Environmental Health Criteria 235: Dermal absorption. World Health Organization, Geneva, Switzerland. http://www.inchem.org/documents/ehc/ehc/ehc235.pdf.